Back
Telix Pharmaceuticals Ltd. 10K Form
Sell
43
TLPPF
Telix Pharmaceuticals Ltd.
Last Price:
$9.16
Seasonality Move:
30.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TLPPF News And Ratings
See the #1 stock for the next 7 days that we like better than TLPPF
TLPPF Financial Statistics
Sales & Book Value
| Annual Sales: | $516.6M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.06 |
| Price / Book: | 25.94 |
Profitability
| EPS (TTM): | 0.03300 |
|---|---|
| Net Income (TTM): | $11.1M |
| Gross Margin: | $336.6M |
| Return on Equity: | 13.56% |
| Return on Assets: | 4.54% |
Telix Pharmaceuticals Ltd. Earnings Forecast
Key Telix Pharmaceuticals Ltd. Financial Ratios
-
The Gross Profit Margin over the past 8 years for TLPPF is 65.16%.
-
The Selling, General & Administrative Expenses for TLPPF have been equal to 27.49% of Gross Profit Margin.
-
The Research & Development expenses have been 24.85% of Revenue.
-
The Interest Expense is 43.00% of Operating Income.
-
The Net Earning history of TLPPF is 6.37% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Telix Pharmaceuticals Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TLPPF |
| Website: | telixpharma.com |
Debt
| Debt-to-Equity Ratio: | 1 |
|---|---|
| Current Ratio: | 2.78 |
| Quick Ratio: | 2.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 96.02 |
|---|---|
| Forward P/E Ratio: | 0 |
TLPPF Technical Analysis vs Fundamental Analysis
Sell
43
Telix Pharmaceuticals Ltd. (TLPPF)
is a Sell
Is Telix Pharmaceuticals Ltd. a Buy or a Sell?
-
Telix Pharmaceuticals Ltd. stock is rated a SellThe current Telix Pharmaceuticals Ltd. [TLPPF] share price is $9.16. The Score for TLPPF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.